SCHEMBL29834896

SCHEMBL29834896

CNC(=O)c1cc(Oc2ccc(NC(=O)c3cc(-c4ccccc4)ccn3)cc2)ccn1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 9/20 0.62
RAF1 P04049 6/20 0.62
EPHX2 P34913 3/20 0.62
MET P08581 2/20 0.60
MAPK14 Q16539 4/20 0.59
HIPK4 Q8NE63 4/20 0.59
PLK4 O00444 2/20 0.59
AURKA O14965 2/20 0.59
MAPK13 O15264 2/20 0.59
MAP4K4 O95819 2/20 0.59
ABL1 P00519 2/20 0.59
LCK P06239 2/20 0.59
FYN P06241 2/20 0.59
LYN P07948 2/20 0.59
RET P07949 2/20 0.59
SRC P12931 2/20 0.59
RPS6KB1 P23443 2/20 0.59
EPHA2 P29317 2/20 0.59
AXL P30530 2/20 0.59
FRK P42685 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27173866 1.00 KDR (0.62) KDRRAF1EPHX2METMAPK14
SCHEMBL29834869 0.91 KDR (0.60) KDRRAF1EPHX2METMAPK14
SCHEMBL26921831 0.91 KDR (0.60) KDRRAF1EPHX2METMAPK14
SCHEMBL26922379 0.90 KDR (0.62) KDRRAF1EPHX2METMAPK14
SCHEMBL29834853 0.90 KDR (0.62) KDRRAF1EPHX2METMAPK14
SCHEMBL29834818 0.90 KDR (0.67) KDRRAF1EPHX2METMAPK14
SCHEMBL29834858 0.90 KDR (0.63) KDRRAF1EPHX2METMAPK14
SCHEMBL27173842 0.90 KDR (0.67) KDRRAF1EPHX2METMAPK14
SCHEMBL29834825 0.90 KDR (0.63) KDRRAF1EPHX2METMAPK14
SCHEMBL26922005 0.90 KDR (0.63) KDRRAF1EPHX2METMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4288539-A1 COMPOSITIONS AND METHODS FOR TREATING DISEASE ASSOCIATED WITH DUX4 OVEREXPRESSION Research Institute at Nationwide Children's Hospital (US) 2023-12-13 EP disclosed
WO-2022169922-A1 COMPOSITIONS AND METHODS FOR TREATING DISEASE ASSOCIATED WITH DUX4 OVEREXPRESSION RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (US) 2022-08-11 WO disclosed